Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation

Physiological Reports

Volumn 2, Issue 12, 2014, Pages

  Stuart, Charles A ^a   Howell, Mary E A ^a   Cartwright, Brian M ^a   McCurry, Melanie P ^a   Lee, Michelle L ^b   Ramsey, Michael W ^b   Stone, Michael H ^b  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Insulin receptor substrate 1; Insulin resistance; Metabolic syndrome; Muscle

Indexed keywords

GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; INSULIN RECEPTOR SUBSTRATE 1; STRESS ACTIVATED PROTEIN KINASE 1;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE TRAINING; FEMALE; GLUCOSE INFUSION; HUMAN; HUMAN TISSUE; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; IMMUNOBLOTTING; INFUSION RATE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; MUSCLE BIOPSY; OBESITY; PROTEIN PHOSPHORYLATION; WEIGHT REDUCTION;

EID: 85003706729     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12236     Document Type: Article

References (28)

1. Aguirre, V., E. D. Werner, J. Giraud, Y. H. Lee, S. E. Shoelson, and M. F. White. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277:1531-1537.
2. Boura-Halfon, S., and Y. Zick. 2009. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296:E581-E591.
3. Bray, G. A., and T. Bellanger. 2006. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29:109-117.
4. De, F. K., and R. A. Roth. 1997. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 36:12939-12947.
5. Flegal, K. M., M. D. Carroll, C. L. Ogden, and L. R. Curtin. 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241.
6. Frost, R. A., and C. H. Lang. 2011. mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) 26:83-96.
7. Gao, Z., D. Hwang, F. Bataille, M. Lefevre, D. York, M. J. Quon, et al. 2002. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 277:48115-48121.
8. Grundy, S. M., H. B. Jr Brewer, J. I. Cleeman, S. C. Jr Smith, and C. Lenfant. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438.
9. Hribal, M. L., M. Federici, O. Porzio, D. Lauro, P. Borboni, D. Accili, et al. 2000. The Gly->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J. Clin. Endocrinol. Metab. 85:2004-2013.
10. Johnston, A. M., L. Pirola, and O. E. Van. 2003. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 546:32-36.
11. Kahn, R., J. Buse, E. Ferrannini, and M. Stern. 2005. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304.
12. Laakso, M., M. Malkki, P. Kekalainen, J. Kuusisto, and S. S. Deeb. 1994. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J. Clin. Invest. 94:1141-1146.
13. Layne, A. S., S. Nasrallah, M. A. South, M. E. Howell, M. P. McCurry, M. W. Ramsey, et al. 2011. Impaired muscle AMPK activation in the metabolic syndrome may Attenuate improved insulin action after exercise training. J. Clin. Endocrinol. Metab. 96:1815-1826.
14. LeBrasseur, N. K., K. Walsh, and Z. Arany. 2011. Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 300:E3-E10.
15. Li, Y., T. J. Soos, X. Li, J. Wu, M. Degennaro, X. Sun, et al. 2004. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J. Biol. Chem. 279:45304-45307.
16. Liberman, Z., and H. Eldar-Finkelman. 2005. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280:4422-4428.
17. Luan, B., J. Zhao, H. Wu, B. Duan, G. Shu, X. Wang, et al. 2009. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149.
18. McCurdy, C. E., and D. J. Klemm. 2013. Adipose tissue insulin sensitivity and macrophage recruitment: does PI3K pick the pathway? Adipocyte 2:135-142.
19. Nikoulina, S. E., T. P. Ciaraldi, S. Mudaliar, P. Mohideen, L. Carter, and R. R. Henry. 2000. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49:263-271.
20. Ozes, O. N., H. Akca, L. D. Mayo, J. A. Gustin, T. Maehama, J. E. Dixon, et al. 2001. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl Acad. Sci. USA 98:4640-4645.
21. Polonsky, K. S. 2012. The past 200 years in diabetes. N. Engl. J. Med. 367:1332-1340.
22. Reeds, D. N., C. A. Stuart, O. Perez, and S. Klein. 2006. Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans. Metabolism 55:1658-1663.
23. Saltiel, A. R., and C. R. Kahn. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806.
24. Sigal, R. J., A. Doria, J. H. Warram, and A. S. Krolewski. 1996. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 81:1657-1659.
25. Stuart, C. A., D. Yin, M. E. A. Howell, R. J. Dykes, J. J. Laffan, and A. A. Ferrando. 2006. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle. Am. J. Physiol. Endocrinol. Metab. 291:E1067-E1073.
26. Stuart, C. A., M. A. South, M. L. Lee, M. P. McCurry, M. E. Howell, M. W. Ramsey, et al. 2013. Insulin responsiveness in metabolic syndrome after eight weeks of cycle training. Med. Sci. Sports Exerc. 45:2021-2029.
27. Wilson, E. M., and P. Rotwein. 2007. Selective control of skeletal muscle differentiation by Akt1. J. Biol. Chem. 282:5106-5110.
28. Yi, Z., P. Langlais, E. A. De Filippis, M. Luo, C. R. Flynn, S. Schroeder, et al. 2007. Global assessment of regulation of phosphorylation of insulin receptor substrate-1 by insulin in vivo in human muscle. Diabetes 56:1508-1516.